Physician profile
Dannah Farah
NPI 1275094401
$1,451.85
in general payments reported to CMS, 2019-2025
14 companies · $336 in 2025
The $336 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $247 · 2023: $540 · 2024: $328 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,204.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $535.35 | 2022-2024 | Xarelto |
| Boston Scientific Corporation | $146.13 | 2024 | Apollo Esg System |
| Inari Medical, INC. | $144.33 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Spinal Simplicity, LLC | $136.47 | 2022 | |
| Alnylam Pharmaceuticals INC. | $125.00 | 2023 | Amvuttra |
| Novo Nordisk INC | $89.17 | 2025 | Wegovy, Ozempic |
| Novartis Pharmaceuticals Corporation | $70.38 | 2025 | |
| Pfizer INC. | $50.42 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $45.36 | 2025 | Airsupra, Breztri |
| Amgen INC. | $38.41 | 2025 | Evenity, Prolia |
| Exact Sciences Corporation | $26.94 | 2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.63 | 2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.76 | 2025 | Lifevest |
| Ibsa Pharma INC. | $13.50 | 2025 | Flector, Licart, Tirosint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dannah Farah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.